Navigation Links
Follow-Up Tests of Leading Personal Care and Household Cleaning Brands Reveal Significant Improvements in Levels of Carcinogenic 1,4-dioxane
Date:2/27/2009

But New Study Indicates Many Products Mislabeled as 'Natural' and 'Organic' Should Still Have Cancer Warning

ANAHEIM, Calif., Feb. 27 /PRNewswire-USNewswire/ -- On Friday, March 6, 2009 a follow-up study on 1,4-dioxane contamination in consumer products commissioned by the Organic Consumers Association (OCA), a watchdog group with over 500,000 members, and overseen by environmental health consumer advocate David Steinman (author of The Safe Shopper's Bible), will be released. The study analyzes leading major "natural" and "organic" as well as conventional brand shampoos, body washes, dish soap and other personal care and cleaning products which come in contact with human skin for the presence of the undisclosed carcinogenic petrochemical contaminant 1,4-dioxane. The independent third-party laboratory, Bodycote Testing Group, known for rigorous testing and chain-of-custody protocols, performed all testing.

The results indicate significant improvement for products from sixteen major brands coinciding with public announcements of test results beginning in February 2007, and lawsuits from the California Attorney General's office in June 2008 (following release of test results in March 2008). The OCA pledges to keep up the pressure until every brand claiming to be "natural" or "organic" removes 1,4-dioxane and other carcinogenic or problematic chemicals from their products.

WHO: David Steinman, Environmental Health Consumer Advocate

Ronnie Cummins, Executive Director, Organic Consumers Association

WHAT: Press conference on 1,4-dioxane in "Natural" and "Organic" Personal Care and Household Cleaning Products

WHEN: Friday, March 6, 2009, 9:00 a.m. PST to coincide with the Natural Products Expo West

WHERE: Anaheim Hilton, 777 Convention Way, Anaheim CA, 92802, Coronado Room 4th Floor

BACKGROUND

Ethoxylation, a cheap shortcut companies use to provide mildness to harsh cleaning ingredients, requires the use of the cancer-causing petrochemical ethylene oxide, which generates 1,4-dioxane as a byproduct. 1,4-dioxane is considered a chemical "known to the State of California to cause cancer" under proposition 65, and has no place in "natural" or "organic" branded personal care products. 1,4-dioxane is also suspected as a kidney toxicant, neurotoxicant and respiratory toxicant, among others, according to the California EPA, and is a significant groundwater contaminant. While previous studies have revealed the presence of 1,4-dioxane in "natural" and conventional products, this latest study shows the toxin is being significantly reduced as brands reformulate.

Further Resources

OCA Facts about 1,4-dioxane: www.organicconsumers.org/bodycare/DioxaneFacts080314.pdf

2008 Press Release and Results: http://www.organicconsumers.org/bodycare/DioxaneRelease08.cfm

Lawsuits from the CA Attorney General's office: www.organicconsumers.org/articles/article_12797.cfm

Campaign for Safe Cosmetics: http://safecosmetics.live.radicaldesigns.org/article.php?id=221

Environmental Working Group: www.ewg.org/chemindex/chemicals/23481


'/>"/>
SOURCE Organic Consumers Association
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. National Coalition for Cancer Survivorship, UCLA, WellPoint, and Genentech Launch Initiative to Provide Coordinated Follow-Up Care for People Surviving Cancer
2. New Research Shows Dental Implants Require Significantly More Follow-Up Treatment Than Root Canals
3. MedImmune grants 5 new fellowships to help expand premature infant follow-up care research
4. "PEACE of Heart" Campaign Comes to Metro Washington to Help Fight Heart Disease Epidemic among Minorities : Hallmark of Campaign's Health Screening Events Is Personalized Follow-Up
5. Many colorectal cancer survivors do not receive recommended follow-up care
6. Blacks, Hispanics less likely than whites to receive follow-up radiation for early breast cancer
7. More patients with drug-coated cardiac stents survive, avoid costly follow-up procedures
8. Incidental adrenal masses commonly seen on CT are usually benign; no follow-up needed
9. 6-month follow-up diagnostic mammograms recommended for women with probably benign lesions
10. Millions of Euros could be saved if breast cancer follow-ups were led by specialist nurses
11. WHI follow-up study: Risks of long-term hormone therapy continue to outweigh benefits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... 21, 2017 , ... The Visiting Nurse Association of ... R. Bard Foundation, Inc. to support the music therapy program offered at ... the nonprofit home care agency. Using evidence-based methods, professionally trained and certified music ...
(Date:7/21/2017)... ... July 21, 2017 , ... ... Tears® EyeMist®, the signature product of her research center at Bio-Logic Aqua Research® ... largest population and the greatest number of sufferers of blindness. “We think that ...
(Date:7/21/2017)... TORONTO, ONTARIO, CANADA (PRWEB) , ... July 21, ... ... repair a torn anterior cruciate ligament (ACL) offer patients improved quality of life ... Orthopaedic Society for Sports Medicine’s Annual Meeting in Toronto, Ontario, Canada. The ...
(Date:7/20/2017)... Va. (PRWEB) , ... July 20, 2017 , ... ... McCarter, MD, has joined JenCare Senior Medical Center as Richmond Chief Medical ... Virginia School of Medicine, and Associate Chief Medical Officer of Ambulatory Services for the ...
(Date:7/20/2017)... (PRWEB) , ... July 20, 2017 , ... ... law firm headquartered in Houston, is pleased to announce their expansion to the ... affordable housing experience, directors Alysse Hollis and Ronald Bell, and of counsels, John ...
Breaking Medicine News(10 mins):
(Date:7/21/2017)... -- Endo International plc (NASDAQ: ENDP ) today ... manufacturing network, the Company will be ceasing operations and ... Huntsville, Alabama . The closure of the facilities ... to 18 months. The Huntsville ... products and these restructuring actions are intended to better ...
(Date:7/20/2017)... -- Prime Therapeutics LLC (Prime) released this statement from its Chief ... for Clinical and Economic Review,s (ICER) public meeting ... of abuse-deterrent formulations (ADF) of opioids. Prime was the sole ... "The ICER data ... use of abuse-deterrent formulations (ADF) in opioids in terms of ...
(Date:7/17/2017)... , July 17, 2017  MedX Holdings, Inc., ... medical testing, strengthening and rehabilitation equipment, today announced the ... Program. MedX is considered the gold standard for the ... in specialized medical strengthening equipment. ... lease with the physician or practice who prescribe the ...
Breaking Medicine Technology: